Vaccine safety

Publication

Overview of EU/EEA country recommendations on COVID-19 vaccination with Vaxzevria, and a scoping review of evidence to guide decision-making

Technical report -

Peer-Reviewed Publication

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines

Dec 2020

Data

Video on vaccination: Monitoring the safety of vaccines in Europe

Video -

Data

Video on vaccination: How vaccines are approved in Europe

Video -

Data

Evidence of the safety of the HPV vaccines in males

Data set -

Data

Evidence of the safety of the HPV vaccine in HIV-infected men and women

Data set -

Data

Evidence of the safety of the 9vHPV vaccine

Data set -

Peer-Reviewed Publication

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines

Oct 2019

Peer-Reviewed Publication

Are we missing respiratory viral infections in infants and children? Comparison of a hospital-based quality management system with standard of care

Jan 2019

Peer-Reviewed Publication

Human papillomavirus vaccination coverage, policies, and practical implementation across Europe

Jan 2019

Peer-Reviewed Publication

Vaccines, trust and European public health

Jan 2018

Peer-Reviewed Publication

Are we missing respiratory viral infections in infants and children? Comparison of a hospital-based quality management system with standard of care

Jan 2018

Peer-Reviewed Publication

Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward

Jan 2018

Publication

Expert opinion on rotavirus vaccination in infancy

Expert opinion -

Peer-Reviewed Publication

Immunisation information systems - Useful tools for monitoring vaccination programmes in EU/EEA countries, 2016

Jan 2017

Peer-Reviewed Publication

Vaccine hesitancy among healthcare workers in Europe: A qualitative study

Jan 2016

Peer-Reviewed Publication

Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?

Jan 2016

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

23 Oct 2015
Geneva, Switzerland

Publication

Vaccine hesitancy among healthcare workers and their patients in Europe

Technical report -

News

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2

ECDC comment -

Peer-Reviewed Publication

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines

Mar 2015

Peer-Reviewed Publication

Safety of human papillomavirus vaccines: A review

Feb 2015

News

Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands

ECDC comment -

Peer-Reviewed Publication

Monitoring and assessing vaccine safety: A European perspective

Apr 2014

Peer-Reviewed Publication

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: A multinational self-controlled case series in Europe

Jan 2014

Peer-Reviewed Publication

The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation

Jan 2014

News

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland

ECDC comment -

Peer-Reviewed Publication

Modelling the risk-benefit impact of H1N1 influenza vaccines

Aug 2013

News

New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix

ECDC comment -

News

Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)

ECDC comment -

Peer-Reviewed Publication

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

Jan 2013

News

Narcolepsy and Pandemrix Vaccine – an association in adults as well as childrenArchived

ECDC comment -

Publication

Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation

Technical report -

Publication

Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination

Technical report -

Peer-Reviewed Publication

Opportunities and challenges of Web 2.0 for vaccination decisions

May 2012

News

Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of IrelandArchived

ECDC comment -

Peer-Reviewed Publication

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark

Apr 2012

News

Association of childhood narcolepsy and cataplexy and receipt of a pandemic influenza vaccine in Finland in 2009-10 – First papers in a peer review journalArchived

ECDC comment -

Event

Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived

23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden

News

Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb StudyArchived

ECDC comment -

News

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate VaccineArchived

ECDC comment -

News

Recommendation by the European Medicines Agency concerning Pandemrix vaccination and reports of narcolepsy in children and adolescentsArchived

ECDC comment -

News

EMA's Committee for Medicinal Products for Human Use (CHMP) issues opinion on narcolepsy and vaccination with Pandemrix®Archived

News -

News

No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived

ECDC comment -

News

Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescentsArchived

ECDC comment -

Peer-Reviewed Publication

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe

Jul 2011

News

The real issues in vaccine safetyArchived

ECDC comment -

News

European Medicines Agency (EMA) 2009 Influenza Pandemic EvaluationArchived

ECDC comment -

News

Narcolepsy following pandemic influenza A H1N1 2009 vaccination - ECDC update: the European Medicines Agency interim measures for PandemrixArchived

ECDC comment -

News

Swedish MPA publishes interim results of a cohort study assessing the risk of narcolepsy after vaccination with Pandemic influenza vaccine Pandemrix®Archived

ECDC comment -

News

Reports of cases of narcolepsy and cataplexy in children and adolescents in Finland, Iceland, and SwedenArchived

ECDC comment -

News

ECDC – VAESCO investigation into narcolepsyArchived

ECDC comment -

Peer-Reviewed Publication

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

Jan 2011

Peer-Reviewed Publication

Moderate pandemic, not many dead - Learning the right lessons in Europe from the 2009 pandemic

Sep 2010

Peer-Reviewed Publication

Measles still spreads in Europe: Who is responsible for the failure to vaccinate?

Apr 2010

Peer-Reviewed Publication

Experience and lessons from surveillance and studies of the 2009 pandemic in Europe

Jan 2010

Peer-Reviewed Publication

Pandemic influenza A(H1N1) 2009 vaccines in the European Union.

Oct 2009

Peer-Reviewed Publication

Assessing vaccines and vaccination programmes in the field

Mar 2009

Peer-Reviewed Publication

A Human Case Of Swine Influenza Virus Infection In Europe - Implications For Human Health And Research

Feb 2009

Peer-Reviewed Publication

Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings

Apr 2008

Peer-Reviewed Publication

European Immunization Week 2008 - time for reflection.

Apr 2008

Peer-Reviewed Publication

European Centre for Disease Prevention and Control issues guidance for the introduction of human papillomavirus (HPV) vaccines in European Union countries.

Jan 2008